表紙
市場調査レポート

性病関連の各種提携契約:契約条件・合意内容

Global Sexual Health Partnering 2010-2016: Deal trends, players and financials

発行 Current Partnering, a division of Wildwood Ventures Limited 商品コード 250311
出版日 ページ情報 英文 250+ Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
性病関連の各種提携契約:契約条件・合意内容 Global Sexual Health Partnering 2010-2016: Deal trends, players and financials
出版日: 2016年02月01日 ページ情報: 英文 250+ Pages
概要

当レポートでは、世界各国における近年の性病関連の各種提携契約の動向について分析し、全体的な取引件数・金額の動向や構造、大手企業の動向、取引種類/開発段階/技術別および適応症別の詳細動向などを調査して、その結果を概略以下の構成でお届けします。

エグゼクティブ・サマリー

第1章 イントロダクション

第2章 性病関連の各種契約の動向

  • イントロダクション
  • 過去数年間の性病関連の各種提携動向
  • 大手製薬企業の性病関連の契約締結活動
  • 性病関連の契約締結に積極的でない大手製薬企業
  • 性病関連の各種提携:取引の種類別
  • 性病関連の各種提携:産業別
  • 性病関連の各種提携:開発段階別
  • 性病関連の各種提携:技術の種類別
  • 性病関連の各種提携:適応症別
  • 性病関連提携の平均的な契約条件
    • 支払総額
    • 前払い金
    • パイルストーン払い
    • ロイヤルティ料率

第3章 性病関連の代表的な取引

  • イントロダクション
  • 主要取引:契約金額別
  • 大手製薬企業の関与がある、代表的な取引

第4章 大手製薬企業の性病関連の契約

  • イントロダクション
  • 大手製薬企業の提携取引の活用方法
  • 企業プロファイル
    • Abbott
    • Bayer
    • GlaxoSmithKline
    • Menarini
    • Merck & Co
    • Mylan
    • Pfizer
    • Roche
    • Teva
    • Valeant
    • Warner Chilcott
    • Watson

第5章 性病関連提携取引の一覧

  • イントロダクション
  • 取引の種類別
    • 資産購入
    • 共同研究開発(R&D)
    • 開発
    • 流通
    • 合弁事業
    • ライセンス
    • 製造
    • マーケティング
    • 材料移動
    • 調停
    • 補助的契約(サブコントラクト)
    • 契約終了
  • 開発段階別
    • 定式化
    • 市販
    • フェーズII
    • フェーズIII
    • 前臨床
    • 規制
  • 技術の種類別
    • 生物学的化合物
    • 装置
    • 診断手法
    • ドラッグデリバリ
    • 小分子

第6章 性病関連の取引動向:適応症別

  • イントロダクション
  • 適応症別の取引件数
    • 性病
    • 細菌性膣炎
    • 鵞口瘡カンジダ
    • 避妊
    • 勃起不全(ED)
    • 性機能不全
    • 性感染症(STI)
    • クラミジア
    • 尖圭コンジローム
    • 淋病
    • 帯状疱疹(ヘルペス)
    • 梅毒
    • トリコモナス症

第7章 提携機会

  • オンライン・パートナーリング
  • パートナーリング・イベント
  • 関連資料

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: CP2212

The Global Sexual Health Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the sexual health partnering deals and agreements entered into by the worlds leading healthcare companies

Global Sexual Health Partnering 2010 to 2016 provides the full collection of Sexual Health disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

  • Trends in Sexual Health partnering deals
  • Financial deal terms for headline, upfront and royalty by stage of development
  • Sexual Health partnering agreement structure
  • Sexual Health partnering contract documents
  • Top Sexual Health deals by value
  • Most active Sexual Health dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Sexual Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sexual Health deals.

The report presents financial deal terms values for Sexual Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Sexual Health dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Sexual Health dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Sexual Health deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Sexual Health dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Sexual Health deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Sexual Health partnering deals by specific Sexual Health target announced since 2010. The chapter is organized by specific Sexual Health therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Sexual Health partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Sexual Health partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Sexual Health technologies and products.

Report scope

Global Sexual Health Partnering 2010 to 2016 is intended to provide the reader with an in-depth understanding and access to Sexual Health trends and structure of deals entered into by leading companies worldwide.

Global Sexual Health Partnering 2010 to 2016 includes:

  • Trends in Sexual Health dealmaking in the biopharma industry since 2010
  • Analysis of Sexual Health deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Sexual Health deal contract documents
  • Comprehensive access to over 3500 Sexual Health deal records
  • The leading Sexual Health deals by value since 2010
  • Most active Sexual Health dealmakers since 2010

In Global Sexual Health Partnering 2010 to 2016, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Sexual Health Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 100 sexual health deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

Global Sexual Health Partnering 2010 to 2016 provides the reader with the following key benefits:

  • In-depth understanding of Sexual Health deal trends since 2010
  • Access Sexual Health deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between Sexual Health partner companies
  • Comprehensive access to over 750 links to actual Sexual Health deals entered into by the world's biopharma companies
  • Indepth review of Sexual Health deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner Sexual Health opportunities
  • Uncover companies actively partnering Sexual Health opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Sexual Health dealmaking

  • 2.1. Introduction
  • 2.2. Sexual Health partnering over the years
  • 2.3. Sexual Health partnering by deal type
  • 2.4. Sexual Health partnering by industry sector
  • 2.5. Sexual Health partnering by stage of development
  • 2.6. Sexual Health partnering by technology type
  • 2.7. Sexual Health partnering by therapeutic indication

Chapter 3 -Financial deal terms for Sexual Health partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Sexual Health partnering
  • 3.3. Sexual Health partnering headline values
  • 3.4. Sexual Health deal upfront payments
  • 3.5. Sexual Health deal milestone payments
  • 3.6. Sexual Health royalty rates

Chapter 4 - Leading Sexual Health deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Sexual Health partnering
  • 4.3. List of most active dealmakers in Sexual Health
  • 4.4. Top Sexual Health deals by value

Chapter 5 - Sexual Health contract document directory

  • 5.1. Introduction
  • 5.2. Sexual Health partnering deals where contract document available

Chapter 6 - Sexual Health dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Sexual Health therapeutic target

Appendices

  • Appendix 1 - Directory of Sexual Health deals by company A-Z 2010 to 2016
  • Appendix 2 - Directory of Sexual Health deals by deal type 2010 to 2016
  • Appendix 3 - Directory of Sexual Health deals by stage of development 2010 to 2016
  • Appendix 4 - Directory of Sexual Health deals by technology type 2010 to 2016
  • Further reading on dealmaking
  • Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering

Table of figures

  • Figure 1: Sexual Health partnering since 2010
  • Figure 2: Sexual Health partnering by deal type since 2010
  • Figure 3: Sexual Health partnering by industry sector since 2010
  • Figure 4: Sexual Health partnering by stage of development since 2010
  • Figure 5: Sexual Health partnering by technology type since 2010
  • Figure 6: Sexual Health partnering by indication since 2010
  • Figure 7: Sexual Health deals with a headline value
  • Figure 8: Sexual Health deals with upfront payment values
  • Figure 9: Sexual Health deals with milestone payment
  • Figure 10: Sexual Health deals with royalty rates
  • Figure 11: Active Sexual Health dealmaking activity- 2010 to 2016
  • Figure 12: Top Sexual Health deals by value since 2010
Back to Top